Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo

Recombinant human EPO-FC fusion proteins with prolonged half-life and enhanced erythropoietic activity in vivo

US Patent 11279742 · Granted Mar 22, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Display panel and display device2025
Display panel, manufacturing method thereof and display device2025
Method for manufacturing display panel, display panel and to-be-cut display pane2025
Reactor secondary side passive residual heat removal system2025
Ion energy control on electrodes in a plasma reactor2025
Thermal management system and valve thereof2025
Method and equipment for transporting nuclear fuel of nuclear power plant2025
Interleukin-15 (IL-15) fusion proteins and uses thereof2025
Cytokine-based bioactivatable drugs and methods of uses thereof2025
MEMS micromirror with high duty cycle, micromirror array and preparation method 2025
Safety management and control system for full lifecycle of industrial control da2025
CD19-based chimeric antigen receptor and application thereof2025